Dow Down 0.32% Nasdaq Up 0.18%

Curis, Inc. (CRIS)

-NasdaqGM
1.68 Down 0.07(4.01%) 2:17PM EDT - Nasdaq Real Time Price
Prev Close:1.75
Open:1.75
Bid:1.67 x 18100
Ask:1.68 x 3100
1y Target Est:5.17
Beta:0.93
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.67 - 1.77
52wk Range:1.53 - 4.74
Volume:453,789
Avg Vol (3m):1,092,040
Market Cap:144.48M
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CRISDown 4.01%144.48M
EXELDown 54.35%368.74M
INFIDown 3.10%532.02M
PFEDown 0.24%185.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.18
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback